The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader ...
Unlike a traditional X-ray, which produces a static image, vertebral motion analysis (VMA) provides doctors with a view of ...
Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the disruption of nerve signals and various associated neurological symptoms, ranging from vision problems to numbness, ...
Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...
A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.
The new 60-second commercial sees Sheen reciting William Tyler Page’s 'The American’s Creed.' By Alex Weprin Senior Editor Over seven seasons of The West Wing, Martin Sheen played President Jed ...
“Forever chemicals” are synthetic compounds found in products like non-stick pans, waterproof clothing, dental floss and more items Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has ...
A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS). The research, published in the journal Environmental International, discovered that ...
Shares of Sanofi slumped on Monday as the French drugmaker said a U.S. regulatory review of its multiple-sclerosis drug won’t be completed by the end of the year and a trial for a different form of MS ...
Fertility-sparing surgery is a safe option for women with early-stage cervical cancer who want to have children, researchers reported. As Janneke T. Wolswinkel, MD, of Radboud University Medical ...
Sanofi SAN-1.37%decrease; red down pointing triangle shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key ...